Pandion raises $58M series A

Pandion Therapeutics Inc. (Cambridge, Mass.) raised $58 million in a tranched series A round co-led by existing investor Polaris Partners and new investors Versant Ventures and Roche Venture Fund. BioInnovation Capital and SR One, also new investors, participated.

Pandion is developing bispecific antibodies designed to locally restore immune homeostasis at the site of inflammatory and autoimmune disease. ...